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ABSTRACT 
Background: Retrobulbar anesthesia is widely used for ocular surgery. 
Ocular complications are possible when retrobulbar anesthesia is accidentally 
injected intravitreally. 
Objective: The aim of this study was to determine the relative retinal toxici- 
ties of ropivacaine hydrochloride, a local anesthetic, using various concentra- 
tions in guinea pigs. 
Methods: This randomized, investigator-masked, experimental study was 
conducted at the Department of Anesthesiology, Dicle University, Diyarbakir, 
Turkey. The right eyes of 18 guinea pigs were assigned to 1 of 3 treatment 
groups: 1%, 0.75%, or 0.5% ropivacaine. The right eye of each animal was 
injected intravitreally with 0.1 mL of 1%, 0.75%, or 0.5% ropivacaine. The left 
eye of each animal was injected with a balanced saline solution (control). The 
guinea pigs were euthanized 7 days after injection, and the retinal structures 
were examined using light microscopy. The total thickness of each retina was 
measured using an ocular micrometer. 
Results: No histologic abnormalities were observed in the control eyes. 
Retinal damage of most of the retinal section was seen in the eyes receiving 
study drug. The eyes injected with 0.5% ropivacaine had a generally intact 
appearance, with the exception of some atrophy and disorganization. Overall, 
the eyes injected with 1% ropivacaine had significantly more extensive retinal 
thinning compared with the eyes injected with 0.75% or 0.5% ropivacaine 
(both, P < 0.01). In the eyes injected with 0.75% or 1% ropivacaine, disorgani- 
zation of the structure of the retinal layers and atrophy were noted on 
histopathology. The mean total thicknesses of the retina were significantly 
less in all ropivacaine-treated yes compared with that in the controls (P < 
0.001). 
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Conclusions: In this small experimental study, ropivacaine had concentration- 
dependent toxic effects on guinea pig retinas. (Curr Ther Res Clin Exp. 2005;66: 
394-400) Copyright © 2005 Excerpta Medica, Inc. 
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INTRODUCTION 
Although topical and intraocular anesthesia have been successfully used for 
several types of ocular surgery, most commonly for phacoemulsification, 1 
retrobulbar anesthesia is still widely used at many institutions. Direct trauma 
to the eye (eg, optic nerve damage, scleral perforation) occurs in <1 in 1000 
retrobulbar injections worldwide. 2 Severe ocular complications have been 
reported in cases of accidental intravitreal injection of anesthetic agents. 3-5 
Moreover, intravitreal application of local anesthetics has been shown to have 
toxic effects on the retina in vitro. 6 
Ropivacaine hydrochloride is a long-acting local anesthetic agent that has a 
greater margin of safety in terms of cardiac and central nervous system tox- 
icity compared with bupivacaine. T The efficacy and safety of ropivacaine for 
retrobulbar, peribulbar, and topical anesthesia during cataract surgery have 
been well studied. 8-12 
We have previously shown that the application of 1% ropivacaine to the ante- 
rior chamber results in endothelial changes in the cornea in a rat model. 13 
Based on a PubMed search (key terms: retina, ropivacaine, and toxicity; years: 
1965-2005), the present study is the first report of the effects of ropivacaine on 
the retina. 
Because of the potential for posterior diffusion of anesthetics when they are 
administered into the anterior segment or accidentally injected intravitreally, 
the objective of the present study was to determine the effects of ropivacaine 
on the retina in a guinea pig model. 
MATERIALS AND METHODS 
This randomized, investigator-masked, experimental study was conducted 
at the Department of Anesthesiology, Dicle University, Diyarbakir, Turkey. 
Eighteen guinea pigs that were healthy and free of clinical ocular disease were 
used in this study. All procedures were performed according to the Association 
for Research in Vision and Ophthalmology Statement 14for the use of animals in 
ophthalmic and vision research, and the approval of the Committee on Animal 
Research of Dicle University was obtained. 
The right eyes of the guinea pigs were randomly assigned, using a computer- 
generated list of random numbers, to receive 1%, 0.75%, or 0.5% ropivacaine 
(6 eyes per group). All animals were anesthetized with an IM injection of a mix- 
ture of ketamine hydrochloride 50 mg/kg and xylazine hydrochloride 10 mg/kg. 
The right eye of each animal was injected approximately in the middle of the vit- 
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reous cavity (by performing the injection when the needle tip was seen from the 
pupilla) with 0.1 mL of 1%, 0.75%, or 0.5% ropivacaine. The left eyes were simi- 
larly injected with 0.1 mL of balanced saline solution (BSS) (control). Retinas 
were assessed 7 days after intravitreal injection of ropivacaine, as previously 
described. 15The animals were then euthanized using an overdose of anesthetic, 
and the eyes were enucleated. 14 
The specimens were dehydrated in a graded ethanol and xylene series and 
then embedded in paraffin. Sections of the retina (4-1Jm thickness) were ob- 
tained from 2 distinct locations. The sections were stained with hematoxylin 
and eosin, and the histopathologic changes were evaluated using light micro- 
scopy. Measurements were taken, in increments of 100 IJm, to a range of 800 to 
1200 IJm above and below the optic nerve head, according to a previously 
described method. 16 The investigators who examined the specimens and 
measured retinal thickness were masked to treatment assignment. 
Statistical Analysis 
The Kruskal-Wallis and Hollander-Wolfe 1~multiple comparison tests were 
used sequentially for the analysis of the differences in mean total retinal thick- 
nesses between treatments. Statistical analyses were not performed for the 
thicknesses of the retinal ayers, and no power analysis was performed. Values 
were presented as mean (SD). A P value <0.05 was considered statistically 
significant. 
RESULTS 
The figure shows light microscopy of retinas representative of each group 
7 days after injection in the vitreous cavity. The appearance ofthe retinas of the 
control eyes (injected with BSS) was normal, and no histologic abnormalities 
were observed (Figure; part A). In the drug-injected eyes, retinal damage of 
most of the retinal sections was seen. The destruction of the retinal structure 
was more severe in the eyes receiving 1% ropivacaine compared with those 
receiving 0.75% or 0.5% ropivacaine (Figure; part B). In all 6 eyes injected with 
1% ropivacaine, the internal limiting membrane was completely absent and the 
retinal ganglion cell layer had lost its regular structure. Histopathologic differ- 
ences such as atrophy, disorganization, and destruction were seen at the inner 
and outer plexiform layers, the inner and outer nuclear layers, and the outer 
limiting membrane (Figure; part B). 
All of the eyes injected with 0.75% ropivacaine exhibited estruction and loss 
of tissue in the retinal structure, including the inner limiting membrane, gan- 
glion cell layer, plexiform layers, and outer nuclear layer (Figure; part C). The 
eyes injected with 0.5% ropivacaine had a generally intact appearance, with the 
exception of some atrophy and disorganization (Figure; part D). 
The mean measurements of total thickness of the retina are shown in the 
table. Mean thickness was significantly ess in all 3 ropivacaine-treated groups 
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Figure, Light microscopy of guinea pig eyes 7 days after intravitreous injection of 
CA) 0,1 mL of balanced saline solution or 0,1 mL of ropivacaine at a concen- 
tration of (B) lO/o, (C) 0,75% or (D) 0,5%, GCL = ganglion cell layer; ICL = 
inner cell layer; IPL = inner plexiform layer; iNL = inner nuclear layer; OPL = 
outer plexiform layer; ONL = outer nuclear layer, (Hematoxylin and eosin; 
scale bars = 32 pm; magnification, 82×,) 
Table, Morphometric measurements of total retinal thickness (pm) in guinea pig eyes 
7 days after intravitreous injection of ropivacaine or balanced saline solution 
(control), Values are presented as mean ($D), 
1% 0.75% 0.5% 
Ropivacaine Ropivacaine Ropivacaine Control 
(n = 6) (n = 6) (n = 6) (n = 18) 
Retinal thickness 77.16 (6)* 98 (17.8)*t 157.16 (34.8)*t 294.5 (31.8) 
*P < 0.001 versus control. 
fP < 0.01 versus ropivacaine 1%. 
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compared with that in the control group (all, P < 0.001). The eyes injected with 
1% ropivacaine showed significantly more extensive retinal thinning com- 
pared with the groups injected with 0.75% or 0.5% ropivacaine (both, P < 
0.01). 
DISCUSSION 
Based on our literature search, there have been many experimental investiga- 
tions of the toxic effects of the intravitreal application of lidocaine and bupiva- 
caine, 2 agents widely used for retrobulbar and peribulbar anesthesia. 6,IS,Is,19 
However, our search revealed no studies evaluating the toxic effects of ropiva- 
caine on the retina. 
Several in vitro studies have suggested that lidocaine might be toxic to the 
retina. ~,2°,21 Grosskreutz et al ~ examined the effects of lidocaine on rat retinal 
ganglion cells (RGCs) in vitro and in a modified in vivo assay and found that 
lidocaine exhibited ose-dependent toxicity for RGCs in vitro. Lower concen- 
trations (0.5 and 1.0 mM) of lidocaine were nontoxic; however, 2.0, 6.0, and 
12.0 mM of lidocaine killed 25%, 88%, and 99% of the RGCs, respectively. The 
investigators also found that intravitreal lidocaine was toxic to RGCs in a dose- 
dependent manner in the in vivo assay; lidocaine concentrations of 3.0, 7.5, and 
15 mM killed 25%, 38%, and 44% of the RGCs, respectively. 
Mondragon and Frixione 2° found that in vitro lidocaine might interfere with 
the dark-adapting migration of screening pigments in crayfish photoreceptors 
and within the cells of the frog retinal pigment epithelium. The lidocaine- 
induced inhibition of dark adaptation was reversible and dependent on the lev- 
els of calcium and sodium in the interstitial and intracellular fluids. 
In a study by Chebabo et al, 2z isolated chick retinas exposed to lidocaine 
(3-7 mM) in vitro for 30 minutes had a dose-dependent decrease in propagation, 
amplitude, and duration of the slow potential change of spreading depression. 
Liang et al z5 determined that intravitreal injection of 0.2 mL of 0.25% to 2% 
lidocaine, 0.25% to 0.75% bupivacaine, or a mixture of 2% lidocaine and 0.75% 
bupivacaine induced reversible changes in the electroretinograms (ERGs) of 
rabbit retinas but produced no permanent histologic abnormalities. Similarly, 
Anders et a122 evaluated the effect of intracameral injection of 0.15 mL of 1% 
lidocaine on the ERG in humans compared with controls receiving peribulbar 
injection of prilocaine. The ERGs of 15 patients and 15 controls were evaluated 
preoperatively and 40 minutes postoperatively. There was a decrease in the 
b-wave amplitude 40 minutes postoperatively in both groups, but no significant 
between-group differences in implicit times or amplitudes on the ERGs were 
found. Nishide et a119 reported that rabbit corneas and retinas manifested no 
serious functional or histologic hanges after the injection of lidocaine at con- 
centrations <0.2%. Likewise, Zemel et al is found that lidocaine and bupivacaine 
were nontoxic to the rabbit retina at concentrations that are effective for 
retrobulbar anesthesia n clinical use. 
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Clinical reports have also shown transient and permanent adverse effects 
induced by lidocaine. Hoffman and Fine 3 reported a case of sudden complete 
loss of visual acuity after an intracameral injection of 1% lidocaine. Lincoff et al 4 
presented etails of 3 patients who received intraocular lidocaine inadver- 
tently. The first patient had not received a mydriatic, and the lidocaine caused 
immediate dilatation and paralysis of the pupil and diminished visual acuity for 
the ability to count fingers. Retinal function began to improve after 4 hours, and 
both retinal and pupillary functions recovered completely within 16 hours. The 
second patient also recovered completely. However, a permanent field defect 
developed in the third patient. The investigators subsequently examined the 
effects of intraocular lidocaine in an animal model and found that lidocaine 
temporarily paralyzed the pupil in mydriasis and temporarily extinguished the 
b-wave seen on ERG. 
In the present study, ropivacaine induced concentration-dependent histo- 
logic changes and retinal thinning in guinea pigs. A limitation of this study 
might be that the histologic examination was done only 7 days after drug injec- 
tion. The earlier and later retinal changes could be investigated to determine a 
wider range of changes. Functional tests are needed to determine the signifi- 
cance of retinal thinning. Further studies using various drug concentrations, 
ERGs, and electron microscopy are needed to better evaluate the functional 
correlates of the histopathologic changes observed in the present study. 
CONCLUSIONS 
This experimental study showed that at concentrations >0.5% ropivacaine 
injected intravitreally was associated with histopathologic changes in the reti- 
nas of guinea pigs. 
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